Displaying drugs 7201 - 7225 of 9786 in total
Aspartyl-alanyl-diketopiperazine
Aspartyl-alanyl-diketopiperazine is under investigation in clinical trial NCT03349645 (An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee).
Investigational
Aminopentamide
Experimental
Vet approved
(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE
Experimental
N-(3-MERCAPTOPROPANOYL)-D-ALANINE
Experimental
(R)-Praziquantel
(R)-Praziquantel is under investigation in clinical trial NCT02271984 (Relative Bioavailability Trial of L-Praziquantel in Healthy Volunteers).
Investigational
Pivagabine
Pivagabine has been used in trials studying the treatment of Stress and Anxiety.
Investigational
Idrocilamide
Experimental
Tolrestat
Tolrestat (INN) (AY-27773) is an aldose reductase inhibitor which was approved for the control of certain diabetic complications. While it was approved for marketed in several countries, it failed a Phase III trial in the U.S. due to toxicity and never received FDA approval. It was sold under the tradename...
Withdrawn
[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,
Experimental
Isoglutamine
Experimental
Freselestat
Experimental
Investigational
N-acetyl-D-glucosamine-6-phosphate
Experimental
Reidispongiolide A
Experimental
Vapitadine
Vapitadine is an antihistamine that Barrier Therapeutics is developing as a treatment for allergic reactions of the skin, such as those associated with hives and for the itch associated with atopic dermatitis. An advantage of vapitadine over other antihistamines may be the absence of the sedation, even at high doses.
Investigational
Talabostat
Investigational
Displaying drugs 7201 - 7225 of 9786 in total